☰

Gregg W. Van Citters, Ph.D. - Publications

Affiliations: 
2001 University of Southern California, Los Angeles, CA, United States 
Area:
Endocrinology/Metabolism, Diabetes
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Ader M, Stefanovski D, Kim SP, Richey JM, Ionut V, Catalano KJ, Hucking K, Ellmerer M, Van Citters G, Hsu IR, Chiu JD, Woolcott OO, Harrison LN, Zheng D, Lottati M, et al. Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog. Obesity (Silver Spring, Md.). 22: 1238-45. PMID 24123967 DOI: 10.1002/Oby.20625  0.425
2005 Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. American Journal of Physiology. Endocrinology and Metabolism. 288: E454-61. PMID 15522994 DOI: 10.1152/Ajpendo.00203.2004  0.756
2003 Kim SP, Ellmerer M, Van Citters GW, Bergman RN. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes. 52: 2453-60. PMID 14514627 DOI: 10.2337/Diabetes.52.10.2453  0.865
2002 van Citters GW, Kabir M, Kim SP, Mittelman SD, Dea MK, Brubaker PL, Bergman RN. Elevated glucagon-like peptide-1-(7-36)-amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding. The Journal of Clinical Endocrinology and Metabolism. 87: 5191-8. PMID 12414891 DOI: 10.1210/Jc.2002-020002  0.75
2002 Mittelman SD, Van Citters GW, Kirkman EL, Bergman RN. Extreme insulin resistance of the central adipose depot in vivo. Diabetes. 51: 755-61. PMID 11872676 DOI: 10.2337/Diabetes.51.3.755  0.84
2002 Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes. 51: S212-20. PMID 11815482 DOI: 10.2337/Diabetes.51.2007.S212  0.771
2001 Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP, Ellmerer M. Central role of the adipocyte in the metabolic syndrome. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 49: 119-26. PMID 11217141 DOI: 10.2310/6650.2001.34108  0.843
2000 Mittelman SD, Van Citters GW, Kim SP, Davis DA, Dea MK, Hamilton-Wessler M, Bergman RN. Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response. Diabetes. 49: 2116-25. PMID 11118015 DOI: 10.2337/Diabetes.49.12.2116  0.859
2000 Dea MK, Van Citters GW, Ader M, Mittelman SD, Sunehag AL, Bergman RN. Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity. Diabetes. 49: 2087-93. PMID 11118011 DOI: 10.2337/Diabetes.49.12.2087  0.795
1999 Dea MK, Van Citters GW, Ader M, Bergman RN. Troglitazone enhances adipocyte insulin sensitivity without affecting endogenous glucose production in normal dogs Journal of Investigative Medicine. 47: 76A.  0.758
Show low-probability matches.